Healthcare Services

Cellular therapy tracking market overview (2026–2030)

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Cellular Therapy Tracking Market Grow Between 2026 And 2030?

The cellular therapy tracking market has experienced rapid expansion in recent years. Its size is expected to climb from $2.9 billion in 2025 to $3.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.1%. This historical growth can be linked to factors such as increasing clinical trial activity for cell therapies, heightened regulatory scrutiny on advanced therapies, the expansion of personalized medicine programs, the early adoption of digital tracking systems, and the growth in biologics manufacturing.

The cellular therapy tracking market is projected for substantial expansion in the coming years, with its size expected to reach $5.31 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.8%. This anticipated growth is primarily driven by the increasing commercialization of cell and gene therapies, a rising need for real-time therapy visibility, the expansion of decentralized clinical trials, a heightened focus on patient safety and compliance, and increased investment in digital health infrastructure. Major trends during this forecast period include the increasing adoption of end-to-end therapy traceability platforms, growing integration of compliance and reporting software, wider use of real-time supply chain monitoring, the expansion of data-driven workflow optimization tools, and an enhanced focus on regulatory transparency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cellular-therapy-tracking-global-market-report

Which Strong Drivers Are Impacting The Cellular Therapy Tracking Market Growth?

The cellular therapy tracking market is anticipated to expand due to the rising integration of personalized medicine. This medical strategy customizes treatment and prevention plans based on an individual’s distinct genetic profile, way of life, and surroundings. The growing uptake of personalized medicine is largely driven by developments in genomics, allowing for accurate identification of genetic differences and bespoke therapies for patients. Cellular therapy tracking facilitates personalized medicine through precise monitoring and administration of patient-specific cells during the entire therapeutic process. It improves the safety and effectiveness of treatments by offering comprehensive traceability, adherence to regulations, and an optimized workflow for medical professionals. For example, data from February 2024, shared by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicates that the U.S. Food and Drug Administration (FDA) authorized 26 new personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the expanding use of personalized medicine is propelling the growth of the cellular therapy tracking market.

Which Segment Classifications Are Used In The Cellular Therapy Tracking Market Segment Analysis?

The cellular therapy tracking market covered in this report is segmented –

1) By Product Type: Software, Services

2) By Application: Cancer, Cardiovascular Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications

3) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users

Subsegments:

1) By Software: Patient Registry Software, Clinical Trial Management Software, Electronic Data Capture (EDC) Systems, Laboratory Information Management Systems (LIMS), Cell Therapy Supply Chain Management Software, Compliance And Reporting Software, Data Analytics And Visualization Tools

2) By Services: Implementation And Integration Services, Training And Education Services, Consulting Services, Managed Services, Technical Support And Maintenance, Data Security And Compliance Services

Which Trends Are Contributing To Changes In The Cellular Therapy Tracking Market?

Leading companies in the cellular therapy tracking market are concentrating on developing scalable solutions, such as chain of identity (COI) management platforms, to guarantee cell traceability, regulatory adherence, and patient safety. Chain of identity (COI) management platforms are defined as digital systems that monitor and authenticate the identity of patient-specific cells throughout the entire cellular therapy process, thus ensuring traceability and patient safety. For example, in May 2023, TrakCel Limited, a UK-based software company, introduced OCELLOS Core. This latest addition to its OCELLOS suite was specifically designed as a Chain of Identity (COI) management platform for early-stage autologous and personalized cell and gene therapy (CGT) clinical trials. It delivers automated COI tracking, ensuring accurate patient records from the initial enrollment. The pre-configured, validated system can be deployed within 2–3 weeks, providing cost-effective scalability as therapies advance from trials to commercialization. Additionally, it tracks chain of custody events with comprehensive audit trails, which improves compliance and facilitates collaboration.

Which Firms Are Contributing To The Cellular Therapy Tracking Market Ecosystem?

Major companies operating in the cellular therapy tracking market are Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Gilead Sciences Inc., Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Lonza Group Ltd., Nikon Corporation, Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Vericel Corporation, Adaptimmune Therapeutics plc, Medipost Co. Ltd., TrakCel

Get The Full Cellular Therapy Tracking Market Report:

https://www.thebusinessresearchcompany.com/report/cellular-therapy-tracking-global-market-report

Which Region Represents The Largest Share Of The Cellular Therapy Tracking Market?

North America was the largest region in the cellular therapy tracking market in 2025. The regions covered in the cellular therapy tracking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cellular Therapy Tracking Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cellular-therapy-tracking-global-market-report

Browse Through More Reports Similar to the Global Cellular Therapy Tracking Market 2026, By The Business Research Company

Cell Viability Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Therapeutic Drug Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795